Clinical Focus

Previous Articles     Next Articles

Endoscopic treatment of esophagogastric varices in cirrhosis

  

  1. Department of Gastroenterology, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
  • Online:2018-11-05 Published:2018-11-05
  • Contact: Corresponding author: Feng Zhijie, Email:zhijiefeng2005@163.com

Abstract: Variceal bleeding in cirrhosis is a lifethreatening complication of portal hypertension. The primary prophylaxis strategy of esophageal varices is nonselective betablockers (NSBBs) or endoscopic variceal ligation (EVL). EVL is the first choice for acute esophageal varices bleeding. The combination of NSBBs and EVL is the recommended management in the secondary prophylaxis. For gastric varices bleeding, gastroesophageal varices type 1 (GOV1) is recommended for EVL, gastroesophageal varices type 2 (GOV2) and isolated gastric varices (IGV) are recommended for endoscopic tissue glue injection. In the prevention of gastric varices rebleeding, transjugular intrahepatic portosystemic shunt (TIPS) can be applied to GOV2 and IGV, and EVL, NSBBs or endoscopic tissue glue injection can be applied to GOV1. NSBBs or endoscopic tissue glue injection can be used for primary prophylaxis of gastric varices.

Key words: liver cirrhosis, esophageal and gastric varices, endoscopic variceal ligation, endoscopic injection sclerotherapy, endoscopic tissue glue injection